Liu, G., Zhang, S., Qin, H., Ji, C., Guo, H. (2025). A prospective, single-center, single-arm clinical study of adjuvant toripalimab combined with axitinib in non-clear renal cell carcinoma (nccRCC) patients with high-risk recurrence factors (IUNU-RC-102).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.tps613